TW201414478A - 經修飾的透明質酸衍生物及其用途 - Google Patents

經修飾的透明質酸衍生物及其用途 Download PDF

Info

Publication number
TW201414478A
TW201414478A TW102136212A TW102136212A TW201414478A TW 201414478 A TW201414478 A TW 201414478A TW 102136212 A TW102136212 A TW 102136212A TW 102136212 A TW102136212 A TW 102136212A TW 201414478 A TW201414478 A TW 201414478A
Authority
TW
Taiwan
Prior art keywords
hyaluronic acid
acid derivative
composition
treatment
derivative according
Prior art date
Application number
TW102136212A
Other languages
English (en)
Chinese (zh)
Inventor
Pietro Antonino Di
Francesca Cavazza
Paolo Caliceti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW201414478(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of TW201414478A publication Critical patent/TW201414478A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
TW102136212A 2012-10-09 2013-10-07 經修飾的透明質酸衍生物及其用途 TW201414478A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12187828 2012-10-09

Publications (1)

Publication Number Publication Date
TW201414478A true TW201414478A (zh) 2014-04-16

Family

ID=47022522

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102136212A TW201414478A (zh) 2012-10-09 2013-10-07 經修飾的透明質酸衍生物及其用途

Country Status (21)

Country Link
US (1) US20150252120A1 (enExample)
EP (1) EP2906193B1 (enExample)
JP (1) JP2015533190A (enExample)
KR (1) KR20150065861A (enExample)
CN (1) CN104703583A (enExample)
AR (1) AR092922A1 (enExample)
AU (1) AU2013328842A1 (enExample)
BR (1) BR112015007823A2 (enExample)
CA (1) CA2886144A1 (enExample)
CL (1) CL2015000803A1 (enExample)
EA (1) EA201590708A1 (enExample)
HK (1) HK1210941A1 (enExample)
IL (1) IL238103A0 (enExample)
IN (1) IN2015DN02358A (enExample)
MX (1) MX2015004386A (enExample)
PE (1) PE20150713A1 (enExample)
PH (1) PH12015500585A1 (enExample)
SG (1) SG11201501992XA (enExample)
TW (1) TW201414478A (enExample)
WO (1) WO2014056841A1 (enExample)
ZA (1) ZA201503171B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI614005B (zh) * 2014-05-26 2018-02-11 National Taipei University Of Technology 水膠組合物的用途

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202014008682U1 (de) * 2014-07-11 2015-08-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
EP3397241A1 (en) * 2015-12-30 2018-11-07 Asafov, Alexander Vilenovich Formulation for treatment of peripheral joints, spinal joints and/or extracellular matrix elements of connective tissue, method of manufacture and uses
RU2625766C1 (ru) * 2016-07-19 2017-07-18 Александр Ливиевич Ураков Средство для экстренного восстановления голоса при внезапной афонии
CN116891540A (zh) * 2018-03-22 2023-10-17 持田制药株式会社 连接有非甾体抗炎化合物的海藻酸衍生物
EP3793525A4 (en) * 2018-05-16 2022-02-16 Emory University PALLADIUM HYALURONIC ACID PARTICLES AND METHODS OF MANAGEMENT OF CANCER OR ANGIOGENIC DISEASES
CN119176959B (zh) * 2024-09-18 2025-07-04 云南贝泰妮生物科技集团股份有限公司 一种透明质酸-聚乳酸共聚物交联凝胶及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8713662D0 (en) 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
US4839159A (en) 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1251151B (it) 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6585987B1 (en) 1998-11-13 2003-07-01 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
CA2445985A1 (en) 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
ITMI20021666A1 (it) 2002-07-26 2004-01-26 Jasper Ltd Liability Co Derivati dell'acido ialuronico
US20110027357A1 (en) * 2004-02-18 2011-02-03 Isaac Gilinski Compositions and methods for timed release of water-soluble nutritional supplements
US20060134147A1 (en) 2004-12-21 2006-06-22 Avon Products, Inc. Cosmetic compositions having carnitine creatinate and methods for using
CA2593064A1 (en) 2004-12-30 2006-07-06 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
JP5047507B2 (ja) * 2005-09-30 2012-10-10 昭和電工株式会社 カルニチン誘導体及びその塩、皮膚外用剤ならびに化粧料
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
EP1884231A1 (en) 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
CN101677912B (zh) 2007-05-11 2013-06-12 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
EP2162158A2 (en) 2007-05-23 2010-03-17 Allergan, Inc. Coated hyaluronic acid particles
WO2010003797A1 (en) 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI614005B (zh) * 2014-05-26 2018-02-11 National Taipei University Of Technology 水膠組合物的用途

Also Published As

Publication number Publication date
EP2906193B1 (en) 2016-09-28
CA2886144A1 (en) 2014-04-17
KR20150065861A (ko) 2015-06-15
BR112015007823A2 (pt) 2017-07-04
JP2015533190A (ja) 2015-11-19
US20150252120A1 (en) 2015-09-10
HK1210941A1 (en) 2016-05-13
ZA201503171B (en) 2016-11-30
AU2013328842A1 (en) 2015-04-09
PE20150713A1 (es) 2015-05-16
PH12015500585A1 (en) 2015-05-04
IN2015DN02358A (enExample) 2015-09-04
SG11201501992XA (en) 2015-04-29
EP2906193A1 (en) 2015-08-19
WO2014056841A1 (en) 2014-04-17
AR092922A1 (es) 2015-05-06
IL238103A0 (en) 2015-05-31
CL2015000803A1 (es) 2015-08-07
CN104703583A (zh) 2015-06-10
MX2015004386A (es) 2015-06-10
EA201590708A1 (ru) 2015-07-30

Similar Documents

Publication Publication Date Title
JP6995946B2 (ja) 抗酸化物質を含む皮膚充填剤組成物
FI94767C (fi) Ei-terapeuttisesti käytettävät hyaluronihapon täydelliset ja osittaiset esterit
Al-Halaseh et al. A review of the cosmetic use and potentially therapeutic importance of hyaluronic acid
RU2733444C2 (ru) Модифицированная гиалуроновая кислота, способ ее получения и ее применения
EP2906193B1 (en) Modified hyaluronic acid derivatives and use thereof
US20100298259A1 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
WO2014044808A2 (en) Fast-penetration cosmetic dermal filler for topical application
AU2015254602B2 (en) Combination of a hyaluronic acid and of a sulphated polysaccharide
JP5570978B2 (ja) 新規化合物、化粧品用途および薬用化粧品用途におけるその使用、および該化合物を含む組成物
KR101571385B1 (ko) 산성 다당체의 부티르산-포름산 에스테르 혼합물, 및 그의 제조 및 피부 화장료로서의 용도
CN113527537A (zh) 一种左旋维生素c透明质酸酯衍生物及其制备方法和应用
US20100323983A1 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof, and uses thereof
CN113473963A (zh) 化妆品/皮肤病学组合物
KR101003687B1 (ko) 히알루론산계 화합물, 그 제조방법 및 용도
KR101917026B1 (ko) 피부 주름 개선 또는 예방용 화장료 조성물
CN115215948A (zh) 一种低分子的乙酰透明质酸脱羧肌肽衍生物、制备方法及应用
Onwubu et al. Biobased materials in skin rejuvenation
EP3863725B1 (en) Nail compositions having antifungal properties
JP2026512119A (ja) ヒアルロン酸分解遅延活性を有する新規ペプチド及びその用途
HK40059997B (en) Nail compositions having antifungal properties
HK40059997A (en) Nail compositions having antifungal properties
FR2932381A1 (fr) Composition cosmetique ou pharmaceutique contenant une association de hyaluronane reticule ou non reticule et d'heparine et/ou un ou plusieurs derives heparinoides pour voie topique et injectable